| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |